Accessibility to cancer medicines under discussion
By Zainul Dawood
Share
DURBAN - DISCUSSIONS are taking place at a global level with the World Health Organisation (WHO), pharmaceutical industries and other stakeholders as to what constitutes a fair price for cancer medicines.
Professor Fatima Suleman at UKZN stated this during a webinar hosted by University of KwaZulu-Natal (UKZN) and World Health Organization Collaboration Centre (WHO CC) for Pharmaceutical Policy and Evidence Based Practice on Tuesday.
Suleman highlighted the imbalance of medicine access and possible solutions to ensure equitable access.
“The cost of the whole cancer care pipeline and hidden costs of chemotherapy and transport are not factored into the cancer care. Medicines play a big role, even those on medical schemes. It can force people to go into bankruptcy,” she said.
This week: Moving from awareness to action on mental he dailymaverick.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymaverick.co.za Daily Mail and Mail on Sunday newspapers.